3B BlackBio Biotech India: 3B Blackbio Dx Limited Reports Earnings Results for the Nine Months Ended December 31, 2023

3B Blackbio Dx Limited reported earnings results for the nine months ended December 31, 2023. For the nine months, the company reported sales was INR 511.27 million compared to INR 437.26 million a... 3B Blackbio Dx Limited reported earnings results for the nine months ended December 31, 2023. For the nine months, the company reported sales was INR 511.27 million compared to INR 437.26 million a year ago. Revenue was INR 594.65 million compared to INR 497.98 million a year ago. Net income was INR 238.65 million compared to INR 181.44 million a year ago. Basic earnings per share from continuing operations was INR 27.21 compared to INR 24.21 a year ago. Diluted earnings per share from continuing operations was INR 27.21 compared to INR 24.21 a year ago.